ClinicalTrials.Veeva

Menu

Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair (ReChord)

N

NeoChord

Status

Enrolling

Conditions

Mitral Valve Insufficiency

Treatments

Device: NeoChord DS1000
Device: Surgical Mitral Valve Repair

Study type

Interventional

Funder types

Industry

Identifiers

NCT02803957
NeoChord: PR-610405-100

Details and patient eligibility

About

The objective of this trial is to assess the safety and effectiveness of the study device in subjects with degenerative mitral valve disease receiving a mitral valve repair without cardiopulmonary bypass (treatment group) when compared to subjects receiving mitral valve repair using standard surgical techniques with cardiopulmonary bypass (control group).

Enrollment

585 estimated patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Is a candidate for mitral valve repair with cardiopulmonary bypass
  • Has Grade III moderate or Grade IV severe degenerative mitral valve regurgitation
  • Primary segmental prolapse of the A2 or P2 segment or prolapse extending to an adjacent segment (P1, P3, A1, A3) who have a single eccentric regurgitant jet on echocardiogram
  • Anterior leaflet covers at least 65% of anterior-posterior annular distance or an anterior leaflet that would provide sufficient coaptation after chord placement
  • Anatomic and general suitability

Exclusion criteria

  • Prior mitral valve surgery
  • Concomitant cardiac procedures
  • Other cardiac procedures within 3 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

585 participants in 2 patient groups

Treatment Group
Experimental group
Description:
Subjects with degenerative mitral valve insufficiency treated with artificial chordae implanted using the NeoChord DS1000
Treatment:
Device: NeoChord DS1000
Control Group
Active Comparator group
Description:
Subjects with degenerative mitral valve insufficiency treated with standard surgical mitral valve repair
Treatment:
Device: Surgical Mitral Valve Repair

Trial contacts and locations

18

Loading...

Central trial contact

David H Adams, MD; Michael Borger, MD, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems